Quality assessment metrics for whole genome gene expression profiling of paraffin embedded samples

BMC Research Notes

Volumn 6, Issue 1, 2013, Pages

  Mahoney, Douglas W ^a   Therneau, Terry M ^a   Anderson, S Keith ^a   Jen, Jin ^a   Kocher, Jean Pierre A ^a   Reinholz, Monica M ^b   Perez, Edith A ^c   Eckel Passow, Jeanette E ^a  

^a MAYO CLINIC   (United States)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c MAYO CLINIC   (United States)

Author keywords

Formalin Fixed; High dimensional array quality; Outlier detection; Paraffin embedded tissue

Indexed keywords

COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; PACLITAXEL; PARAFFIN; RNA; TRASTUZUMAB;

ARTICLE; BREAST TUMOR; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; HUMAN GENOME; METABOLISM; METHODOLOGY; PHASE 3 CLINICAL TRIAL (TOPIC); QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL MODEL; PROCEDURES;

ANTIBODIES, MONOCLONAL, HUMANIZED; BREAST NEOPLASMS; CLINICAL TRIALS, PHASE III AS TOPIC; CYCLOPHOSPHAMIDE; DNA, COMPLEMENTARY; DOXORUBICIN; FEMALE; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; MODELS, STATISTICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PACLITAXEL; PARAFFIN EMBEDDING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTOR, ERBB-2; RNA;

EID: 84873027115     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-6-33     Document Type: Article

References (36)

1. Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay. Waddell N, Cocciardi S, Johnson J, Healey S, Marsh A, Riley J, da Silva L, Vargas AC, Reid L, Simpson PT, J Pathol 2010 221 4 452 461 20593485
2. Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens. Sadi AM, Wang DY, Youngson BJ, Miller N, Boerner S, Done SJ, Leong WL, BMC Cancer 2011 11 253 251 213 10.1186/1471-2407-11-253 21679412
3. Gene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL sample preparation. Ton CC, Vartanian N, Chai X, Lin MG, Yuan X, Malone KE, Li CI, Dawson A, Sather C, Delrow J, Breast Cancer Res Treat 2011 125 3 879 883 10.1007/s10549-010-1159-6 20842525
4. Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays. Bibikova M, Talantov D, Chudin E, Yeakley JM, Chen J, Doucet D, Wickham E, Atkins D, Barker D, Chee M, Am J Pathol 2004 165 5 1799 1807 10.1016/S0002-9440(10)63435-9 15509548
5. A versatile assay for high-throughput gene expression profiling on universal array matrices. Fan JB, Yeakley JM, Bibikova M, Chudin E, Wickham E, Chen J, Doucet D, Rigault P, Zhang B, Shen R, Genome Res 2004 14 5 878 885 10.1101/gr.2167504 15123585
6. Gene expression profiles in formalin-fixed, paraffin-embedded tissues obtained with a novel assay for microarray analysis. Bibikova M, Yeakley JM, Chudin E, Chen J, Wickham E, Wang-Rodriguez J, Fan JB, Clin Chem 2004 50 12 2384 2386 10.1373/clinchem.2004.037432 15563488
7. Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples. April C, Klotzle B, Royce T, Wickham-Garcia E, Boyaniwsky T, Izzo J, Cox D, Jones W, Rubio R, Holton K, PLoS One 2009 4 12 8162 10.1371/journal.pone.0008162 19997620
8. Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancer. Fountzilas E, Markou K, Vlachtsis K, Nikolaou A, Arapantoni-Dadioti P, Ntoula E, Tassopoulos G, Bobos M, Konstantinopoulos P, Fountzilas G, Ann Oncol 2012 23 8 2146 2153 10.1093/annonc/mdr576 22219018
9. Gene-expression signature of vascular invasion in hepatocellular carcinoma. Minguez B, Hoshida Y, Villanueva A, Toffanin S, Cabellos L, Thung S, Mandeli J, Sia D, April C, Fan JB, J Hepatol 2011 55 6 1325 1331 10.1016/j.jhep.2011.02.034 21703203
10. Report on emerging technologies for translational bioinformatics: a symposium on gene expression profiling for archival tissues. Waldron L, Simpson P, Parmigiani G, Huttenhower C, BMC Cancer 2012 12 124 10.1186/1471-2407-12-124 22458912
11. Experimental design for gene expression microarrays. Kerr MK, Churchill GA, Biostatistics 2001 2 2 183 201 10.1093/biostatistics/2.2.183 12933549
12. Statistical design and the analysis of gene expression microarray data. Kerr MK, Churchill GA, Genet Res 2001 77 2 123 128 11355567
13. Faster cyclic loess: normalizing RNA arrays via linear models. Ballman KV, Grill DE, Oberg AL, Therneau TM, Bioinformatics 2004 20 16 2778 2786 10.1093/bioinformatics/bth327 15166021
14. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bolstad BM, Irizarry RA, Astrand M, Speed TP, Bioinformatics 2003 19 2 185 193 10.1093/bioinformatics/19.2.185 12538238
15. MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a. Toffanin S, Hoshida Y, Lachenmayer A, Villanueva A, Cabellos L, Minguez B, Savic R, Ward SC, Thung S, Chiang DY, Gastroenterology 2011 140 5 1618 1628 e1616 10.1053/j.gastro.2011.02.009 21324318
16. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Villanueva A, Hoshida Y, Battiston C, Tovar V, Sia D, Alsinet C, Cornella H, Liberzon A, Kobayashi M, Kumada H, Gastroenterology 2011 140 5 1501 1512 e1502 10.1053/j.gastro.2011.02.006 21320499
17. Gene expression profiling of human whole blood samples with the Illumina WG-DASL assay. Winn ME, Shaw M, April C, Klotzle B, Fan JB, Murray SS, Schork NJ, BMC Genomics 2011 12 412 10.1186/1471-2164-12-412 21843359
18. Preprocessing and quality control strategies for illumina DASL assay-based brain gene expression studies with semi-degraded samples. Chow ML, Winn ME, Li HR, April C, Wynshaw-Boris A, Fan JB, Fu XD, Courchesne E, Schork NJ, Front Genet 2012 3 11 22375143
19. Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer. Perez EA, Suman VJ, Davidson NE, Gralow JR, Kaufman PA, Visscher DW, Chen B, Ingle JN, Dakhil SR, Zujewski J, J Clin Oncol 2011 29 34 4491 4497 10.1200/JCO.2011.36.7045 22042958
20. Assessing affymetrix GeneChip microarray quality. McCall MN, Murakami PN, Lukk M, Huber W, Irizarry RA, BMC Bioinforma 2011 12 137 10.1186/1471-2105-12- 137
21. A statistical framework for the analysis of microarray probe-level data. Wu Z, Irizarry RA, Ann Appl Stat 2007 1 333 357 10.1214/07-AOAS116
22. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Huber W, von Heydebreck A, Sültmann H, Poustka A, Vingron M, Bioinformatics 2002 18 suppl 1 96 S104 10.1093/bioinformatics/18.suppl-1.S96 12169536
23. A model for measurement error for gene expression arrays. Rocke DM, Durbin B, J Comput Biol 2001 8 6 557 569 10.1089/106652701753307485 11747612
24. Experimental design and low-level analysis of microarray data. Bolstad BM, Collin F, Simpson KM, Irizarry RA, Speed TP, Int Rev Neurobiol 2004 60 25 58 15474586
25. BeadArray expression analysis using bioconductor. Ritchie ME, Dunning MJ, Smith ML, Shi W, Lynch AG, PLoS Comput Biol 2011 7 12 1002276 10.1371/journal.pcbi.1002276 22144879
26. Multi-level mixed effects models for bead arrays. Kim RS, Lin J, Bioinformatics 2011 27 5 633 640 10.1093/bioinformatics/btq708 21169374
27. Lumi: a pipeline for processing illumina microarray. Du P, Kibbe WA, Lin SM, Bioinformatics 2008 24 13 1547 1548 10.1093/bioinformatics/btn224 18467348
28. Myers RH, Classical and modern regression with applications Boston: PWS-KENT 2 1990
29. Making the most of microarrays. Nat Biotechnol 2006 24 9 1039 16964193
30. The MicroArray quality control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville F, Kawasaki ES, Lee KY, Nat Biotechnol 2006 24 9 1151 1161 10.1038/nbt1239 16964229
31. Evaluation of external RNA controls for the assessment of microarray performance. Tong W, Lucas AB, Shippy R, Fan X, Fang H, Hong H, Orr MS, Chu TM, Guo X, Collins PJ, Nat Biotechnol 2006 24 9 1132 1139 10.1038/nbt1237 16964227
32. Evaluation of DNA microarray results with quantitative gene expression platforms. Canales RD, Luo Y, Willey JC, Austermiller B, Barbacioru CC, Boysen C, Hunkapiller K, Jensen RV, Knight CR, Lee KY, Nat Biotechnol 2006 24 9 1115 1122 10.1038/nbt1236 16964225
33. The MicroArray quality control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Shi L, Campbell G, Jones WD, Campagne F, Wen Z, Walker SJ, Su Z, Chu TM, Goodsaid FM, Pusztai L, Nat Biotechnol 2010 28 8 827 838 10.1038/nbt.1665 20676074
34. Comparison of affymetrix GeneChip expression measures. Irizarry RA, Wu Z, Jaffee HA, Bioinformatics 2006 22 7 789 794 10.1093/bioinformatics/btk046 16410320
35. A cross-study comparison of gene expression studies for the molecular classification of lung cancer. Parmigiani G, Garrett-Mayer ES, Anbazhagan R, Gabrielson E, Clin Cancer Res 2004 10 9 2922 2927 10.1158/1078-0432.CCR-03-0490 15131026
36. Empirical array quality weights in the analysis of microarray data. Ritchie ME, Diyagama D, Neilson J, van Laar R, Dobrovic A, Holloway A, Smyth GK, BMC Bioinforma 2006 7 261 10.1186/1471-2105-7-261